scholarly journals Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat

1995 ◽  
Vol 15 (7) ◽  
pp. 4906-4917 ◽  
Author(s):  
B Marqueze ◽  
JA Boudier ◽  
M Mizuta ◽  
N Inagaki ◽  
S Seino ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Cellular Localization ◽  
Adrenal Glands ◽  
Synaptotagmin I ◽  
The Central Nervous System

Development of adrenomedullary function in suckling rats: Effects of high doses of thyroxine and cortisol

1990 ◽  
Vol 123 (1) ◽  
pp. 100-107
Author(s):  
L. Goya ◽  
C. Aláez ◽  
A. M. Pascual-Leone
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Adrenal Glands ◽  
Normal Development ◽  
Insulin Administration ◽  
Newborn Rats ◽  
Short Intervals ◽  
Slowing Down ◽  
The Central Nervous System ◽  
High Doses

Abstract. The development of epinephrine, norephinephrine, and total catecholamine secretion in plasma and andrenal glands was studied in newborn rats at short intervals: at day 2, 4, 6, 8, 10, 12 and 23. The increase in the plasma level of epinephrine represents a maturation of the secretion of the adrenal medulla. The increase in plasma of epinephrine and norepinephrine and the content of catecholamines in the adrenal glands of both normal animals and those treated with either high doses of T4 or cortisol at birth suggest a slowing down of the normal development of epinephrine secretion. This was confirmed by inducing hypoglycemia in these three groups of animals by a 20-h fast or by insulin administration (0.1436 μmol/kg). We conclude that both high doses of T4 and cortisol administered at birth seem to retard the development of the autonomic nervous system similar to the effect on the central nervous system.

Peripheral and brain tissue catecholamine content in intact and anti-NGF-treated fetal sheep

1987 ◽  
Vol 252 (1) ◽  
pp. R7-R12 ◽  
Author(s):  
J. A. Schuijers ◽  
D. W. Walker ◽  
C. A. Browne ◽  
G. D. Thorburn
Keyword(s):  
Spinal Cord ◽  
Central Nervous System ◽  
Nervous System ◽  
Gestational Age ◽  
Adrenal Glands ◽  
Matched Control ◽  
Cervical Spinal Cord ◽  
Fetal Sheep ◽  
Catecholamine Content ◽  
The Central Nervous System

Fetal lambs were treated with a single dose of anti-mouse nerve growth factor (anti-NGF) at 80 days gestational age. The catecholamine content of tissues was determined at 135 days gestational age. There was a reduction of either norepinephrine, epinephrine, or both, in the thymus, thyroid, atrium (but not ventricle), lung, liver, kidney, and jejunum when compared with age-matched control fetuses. The spleen, ileum, colon, and the adrenal glands were not affected by anti-NGF. In treated fetuses there was a reduction in catecholamine content of the thalamus, hypothalamus, hippocampus, medulla, cerebellum, and cervical spinal cord. These results show that some tissues are sensitive to, and some are refractory to, the action of anti-NGF at 80 days gestation. Also the results suggest that NGF may play a role in the development of catecholamine-containing neurons within the central nervous system.

Non Hodgkin's lymphoma involving the adrenal glands and the central nervous system (CNS): a particular evolution after chemotherapy

2005 ◽  
Vol 66 (6) ◽  
pp. 527-531 ◽  
Author(s):  
F.-L. Vélayoudom ◽  
C. Cardot-Bauters ◽  
A.-V. Decouvelaere ◽  
V. Vlaeminck ◽  
F. Bauters ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Hodgkin’S Lymphoma ◽  
Adrenal Glands ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
The Central Nervous System

scholarly journals The role of the central nervous system in glucose homeostasis

2012 ◽  
Vol 19 (2) ◽  
pp. 207-214 ◽  
Author(s):  
Cristina Muntean ◽  
Maria Mota ◽  
Simona Popa ◽  
Adina Mitrea
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Glucose Homeostasis ◽  
Adrenal Glands ◽  
Firing Rates ◽  
Claude Bernard ◽  
The Central Nervous System ◽  
Extracellular Level ◽  
The One

Abstract Central nervous system, mainly the hypothalamus and the brainstem are importantkeys in glucose homeostasis. Not only do they use glucose as primary fuel for theirfunctioning but they are part of intricate neuronal circuits involved in glucose uptakeand production as was first shown by Claude Bernard. Moreoverelectrophysiological analysis of hypothalamus revealed the existence of glucosensingneurons whose firing rates are controlled by glucose extracellular level. Furtherinformation was obtained regarding the importance of leptin, insulin and free fattyacids as afferent signals received by these neural structures. As for the main efferentpathways, autonomic system is the one connecting CNS with the effector organs (theliver, the pancreas and the adrenal glands).

scholarly journals Dynamic Role of Phospholipases A2 in Health and Diseases in the Central Nervous System

Cells ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 2963
Author(s):  
Grace Y. Sun ◽  
Xue Geng ◽  
Tao Teng ◽  
Bo Yang ◽  
Michael K. Appenteng ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Cellular Localization ◽  
Cell Types ◽  
Molecular Structures ◽  
Specific Cell ◽  
Phospholipases A2 ◽  
Cell Functions ◽  
The Central Nervous System

Phospholipids are major components in the lipid bilayer of cell membranes. These molecules are comprised of two acyl or alkyl groups and different phospho-base groups linked to the glycerol backbone. Over the years, substantial interest has focused on metabolism of phospholipids by phospholipases and the role of their metabolic products in mediating cell functions. The high levels of polyunsaturated fatty acids (PUFA) in the central nervous system (CNS) have led to studies centered on phospholipases A2 (PLA2s), enzymes responsible for cleaving the acyl groups at the sn-2 position of the phospholipids and resulting in production of PUFA and lysophospholipids. Among the many subtypes of PLA2s, studies have centered on three major types of PLA2s, namely, the calcium-dependent cytosolic cPLA2, the calcium-independent iPLA2 and the secretory sPLA2. These PLA2s are different in their molecular structures, cellular localization and, thus, production of lipid mediators with diverse functions. In the past, studies on specific role of PLA2 on cells in the CNS are limited, partly because of the complex cellular make-up of the nervous tissue. However, understanding of the molecular actions of these PLA2s have improved with recent advances in techniques for separation and isolation of specific cell types in the brain tissue as well as development of sensitive molecular tools for analyses of proteins and lipids. A major goal here is to summarize recent studies on the characteristics and dynamic roles of the three major types of PLA2s and their oxidative products towards brain health and neurological disorders.

scholarly journals Refractory neuroblastoma, victory over pain (clinical case)

Pain medicine ◽  
2019 ◽  
Vol 3 (4) ◽  
pp. 64-58
Author(s):  
O O Kalinchuk ◽  
T G Korol ◽  
S S Blazhko ◽  
N U Kosechenko
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Clinical Case ◽  
Adrenal Glands ◽  
Pain Syndrome ◽  
Sympathetic Ganglia ◽  
Protective Mechanism ◽  
Thoracic Cavity ◽  
Oncological Patients ◽  
The Central Nervous System

Neuroblastoma is a malignant tumor that develops from the stem cells of the sympathetic ganglia and the adrenal medulla and belongs to the group of neuroendocrine tumors. It is most often localized in the adrenal glands and the retroperitoneal space, less – in sympathetic ganglia of the neck and thoracic cavity. Pain syn-drome is one of the leading manifestations in patients with disease progression. Unlike other patients, a pain syndrome in oncological patients is not a temporary or periodic sensation, it has no physio-logical expediency, it does not have a protective mechanism, but, on the contrary, pain in this group of patients leads to inadaptation, distorted perception of pain and small impulses, most importantly, accompanied by various disorders of the functions of the central nervous system in the patient’s body.

Sign in / Sign up

Export Citation Format

Share Document